All Documents


Events & Presentations

Investor Video

View Video

Press Releases

Oct 10, 2021
BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with Mantle Cell Lymphoma    read more...
Oct 07, 2021
BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Waldenström’s Macroglobulinemia    read more...
Sep 20, 2021
BeiGene Announces Inclusion in FTSE Russell Indices   
Press Releases

Thank you for your interest in Beigene, Ltd ! You will receive an email shortly. Please confirm your email address by clicking the link inside.

Back to the form